FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

BEHIND THE RESEARCH Previous Volume 349:213-214 July 17, 2003 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Scardino, P. T. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Thompson, I. M. PubMed Citation

It seems that death and taxes are not the only sure things in life anymore. Now, all adults in late middle age must also confront a complex individualized calculation of the risks and benefits of long-term pharmacologic manipulation of the sex hormones.

Women and their doctors learned this lesson last summer, when a large study of postmenopausal estrogen and progesterone supplementation was stopped prematurely, with the finding that the hormones relieved menopausal symptoms and lowered the risks of hip fractures and colon cancer but did so at the price of increased risks of myocardial infarction, stroke, and breast cancer.

Now . . . [Full Text of this Article]

Source Information

From St. Luke's–Roosevelt Hospital Center, New York.

Related Letters:

Prevention of Prostate Cancer with Finasteride
Rubin M. A., Kantoff P. W., Roehrborn C. G., Burke H. B., Schwartz D. T., Ross R. K., Skinner E., Cote R. J., Lee S. C., Ellis R. J., Barzell W. E., Thompson I. M. Jr., Goodman P. J., Coltman C. A. Jr.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:1569-1572, Oct 16, 2003. Correspondence

This article has been cited by other articles:

• Lucia, M. S., Epstein, J. I., Goodman, P. J., Darke, A. K., Reuter, V. E., Civantos, F., Tangen, C. M., Parnes, H. L., Lippman, S. M., La Rosa, F. G., Kattan, M. W., Crawford, E. D., Ford, L. G., Coltman, C. A. Jr, Thompson, I. M. (2007). Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial. JNCI J Natl Cancer Inst 99: 1375-1383 [Abstract] [Full Text]  
• Paskett, E. D., Schrag, D., Kornblith, A., Lamont, E. B., Weeks, J. C., Marshall, J. R., Shapiro, C., Holland, J. (2006). Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.. Clin. Cancer Res. 12: 3601s-3605s [Abstract] [Full Text]  
• Rosner, W. (2004). Proscar and Propecia--A Therapeutic Perspective. J. Clin. Endocrinol. Metab. 89: 3096-3098 [Full Text]  
• Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., Swerdloff, R. S. (2004). Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men. J. Clin. Endocrinol. Metab. 89: 2085-2098 [Abstract] [Full Text]  
• Rubin, M. A., Kantoff, P. W., Roehrborn, C. G., Burke, H. B., Schwartz, D. T., Ross, R. K., Skinner, E., Cote, R. J., Lee, S. C., Ellis, R. J., Barzell, W. E., Thompson, I. M. Jr., Goodman, P. J., Coltman, C. A. Jr. (2003). Prevention of Prostate Cancer with Finasteride. NEJM 349: 1569-1572 [Full Text]  
• Sabichi, A. L., Demierre, M.-F., Hawk, E. T., Lerman, C. E., Lippman, S. M. (2003). Frontiers in Cancer Prevention Research. Cancer Res. 63: 5649-5655 [Full Text]